Blood disorders in extrahepatic portal vein obstruction
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial studies blood disorders in people with extrahepatic portal vein obstruction (a blocked vein outside the liver). It aims to understand how this condition affects blood health and clotting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have been diagnosed with extrahepatic portal vein obstruction (a blockage in the vein outside the liver) using imaging like ultrasound, CT, or MRI.
- Your liver function must be preserved (not damaged or failing).
- You cannot have cirrhosis (scarring) or high blood pressure within the liver.
- You cannot have a blood cancer (like leukemia or lymphoma) or be on chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
This trial tests how a new drug, HSK39297, works in people with mild to moderate liver impairment (Child-Pugh A or B). It compares them to healthy volunteers to see how the liver affects the drug's safety and how the body processes it.
This study tracks people with liver cirrhosis to see how often portal vein thrombosis (a blood clot in the main vein to the liver) occurs and how it can be treated with blood thinners. It aims to improve care for those at risk of these clots.
This study looks at how blood clots in the portal vein (the main vein to your liver) affect recovery and outcomes after a liver transplant. If you've had a liver transplant, your data may help doctors understand this better.
This trial looks at people with clinically significant portal hypertension, which is high blood pressure in the liver's blood vessels. It may help find better ways to manage this condition.
This study tests whether blood thinners (anticoagulants) are safe and effective for people with cirrhosis and a blood clot in the portal vein. It may also include people with liver cancer (HCC).
Hear when a new Thrombophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.